
WntResearch Investor Relations Material
Latest events

Q3 2022
WntResearch
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from WntResearch
Access all reports
WntResearch is a biotechnology company specializing in oncology, focusing on the development of therapies aimed at preventing the spread of cancer. The company's approach involves targeting the metastatic process by researching the endogenous protein WNT5A, which plays a critical role in the mobility and spread of tumor cells within the body. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
WNT
Country
🇸🇪 Sweden